These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 32944388)
21. Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3. Hu FZ; Sheng ZZ; Qin CP; Xu T Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):360-3. PubMed ID: 27469927 [TBL] [Abstract][Full Text] [Related]
22. CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway. Li H; Guo X; Shao L; Plate M; Mo X; Wang Y; Han W BMB Rep; 2010 Mar; 43(3):182-7. PubMed ID: 20356458 [TBL] [Abstract][Full Text] [Related]
23. Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification. Zhang M; Wang J; Yue H; Zhang L Front Genet; 2022; 13():918319. PubMed ID: 36110202 [No Abstract] [Full Text] [Related]
24. Characterization and expression profile of CMTM3/CKLFSF3. Zhong J; Wang Y; Qiu X; Mo X; Liu Y; Li T; Song Q; Ma D; Han W J Biochem Mol Biol; 2006 Sep; 39(5):537-45. PubMed ID: 17002874 [TBL] [Abstract][Full Text] [Related]
25. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells. Li W; Zhang S Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543 [TBL] [Abstract][Full Text] [Related]
26. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth. Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243 [TBL] [Abstract][Full Text] [Related]
27. Bioinformatics-Based Discovery of Zhou J; Lei J; Wang J; Lian CL; Hua L; He ZY; Wu SG Front Cell Dev Biol; 2019; 7():361. PubMed ID: 31998718 [TBL] [Abstract][Full Text] [Related]
28. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer. Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015 [TBL] [Abstract][Full Text] [Related]
29. Impact of CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) expression in gastric cancer. Nishi M; Shimada M; Yoshikawa K; Higashijima J; Tokunaga T; Kashihara H; Takasu C; Eto S; Yoshimoto T J Med Invest; 2021; 68(3.4):362-367. PubMed ID: 34759159 [TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation. Plate M; Li T; Wang Y; Mo X; Zhang Y; Ma D; Han W Mol Cells; 2010 Apr; 29(4):355-61. PubMed ID: 20213316 [TBL] [Abstract][Full Text] [Related]
31. Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. Han W; Ding P; Xu M; Wang L; Rui M; Shi S; Liu Y; Zheng Y; Chen Y; Yang T; Ma D Genomics; 2003 Jun; 81(6):609-17. PubMed ID: 12782130 [TBL] [Abstract][Full Text] [Related]
32. miR-135b-5p promotes gastric cancer progression by targeting CMTM3. Lu M; Huang Y; Sun W; Li P; Li L; Li L Int J Oncol; 2018 Feb; 52(2):589-598. PubMed ID: 29345297 [TBL] [Abstract][Full Text] [Related]
33. [Expression of chemokine like factor-like myelin and lymphocyte and related proteins for vesicle trafficking and membrane link transmembrane domain-containing protein 2 in rats with varicocele]. Zhang XW; Dun YJ; Tang X; Yin HQ; Hu ZP; Zhao YP; Xu T; Li Q Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):579-583. PubMed ID: 29263492 [TBL] [Abstract][Full Text] [Related]
34. SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma. Jin Y; Qin X; Jia G Biochem Biophys Res Commun; 2018 Dec; 507(1-4):91-99. PubMed ID: 30392914 [TBL] [Abstract][Full Text] [Related]
35. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions. Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220 [TBL] [Abstract][Full Text] [Related]
36. Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients: A Potential Indicating Factor for Keloid-Predisposed Individuals. Zhang M; Xu Y; Liu Y; Cheng Y; Zhao P; Liu H; Wang Y; Ma X Medicine (Baltimore); 2016 Mar; 95(11):e3082. PubMed ID: 26986142 [TBL] [Abstract][Full Text] [Related]
37. [Expression and significance of CMTM5 and epidermal growth factor receptor in prostate cancer]. Yuan YQ; Zhang YX; Liu ZH; Qin CP; Sheng ZZ; Xu T; Wang XF Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):571-6. PubMed ID: 26284387 [TBL] [Abstract][Full Text] [Related]
38. Re: CMTM3 Inhibits Human Testicular Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis. Richie JP J Urol; 2015 Sep; 194(3):706-7. PubMed ID: 26292862 [No Abstract] [Full Text] [Related]
39. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma. Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560 [TBL] [Abstract][Full Text] [Related]
40. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells. Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]